European Commission extends approval of cystic fibrosis medicine

For the first time, a medicine for the most common form of cystic fibrosis has been approved in patients aged one to under two years old.

Related Keywords

Sweden ,Austria ,Ireland ,United Kingdom ,Denmark ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Republic Of Ireland ,Silvia Gartner ,Carmen Bozic ,Coordinator Of The Pediatric Cystic Fibrosis Center ,European Commission ,Regulatory Agency ,Vertex Pharmaceuticals ,Global Medicines Development ,Pediatric Cystic Fibrosis Center ,Executive Vice President ,Medical Affairs ,Chief Medical Officer ,